Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW842166 in osteoarthritis of the knee
2006-005914-10Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GW842166 in knee osteoarthritis (OA) (4 arms), sponsored by GSK. Primary endpoint: Change in WOMAC pain subscale score. Started Feb 2007; status: completed.
02
Drugs
GW842166
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2006-005914-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005914-10.